Exjade Dispersible Tablets

Deferasirox (Exjade) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anaemias.

Garvan

Pharmacist - M.B.A. (Public Health) D.I.C.

Exjade Dispersible Tablets

What is Exjade? EXJADE is indicated for…

Garvan J. Lynch
MBA (Public Health)

Join our monthly newsletter and get FREE shipping on your first order and a great discount! Join

What is Exjade?

  • EXJADE is indicated for the treatment of chronic iron overload due to frequent blood transfusions (≥ 7 ml/kg/month of packed red blood cells) in patients with beta thalassemia major aged 6 years and older.

EXJADE is also indicated for the treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:

  • in patients with beta thalassemia major with iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) aged 2 to 5 years
  • in patients with beta thalassemia major with iron overload due to infrequent blood transfusions (
  • in patients with other anemias aged 2 years and older

EXJADE is also indicated for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inadequate in patients with non-trans fusion-dependent thalassemia syndromes aged 10 years and older.

What is the dosage?

Titrate and monitor to reach chelation goals

Monitor serum ferritin monthly and assess trends with steady-state levels

  • Titrate EXJADE by steps of 5 mg/kg/day to 10 mg/kg/day every 3 to 6 months based on individual patient's response and therapeutic goals (maintenance or reduction of iron)
  • EXJADE is approved at doses up to 40 mg/kg/day for patients not adequately controlled with doses of 30 mg/kg (eg, serum ferritin levels persistently above 2,500 µg/L and not showing a decreasing trend over time)
  • Doses above 40 mg/kg are not recommended because there is only limited experience with doses above this level
  • Dose reductions, in steps of 5 to 10 mg/kg, should be considered in patients whose serum ferritin levels have reached the target (usually between 500 and 1000 µg/L) in order to maintain serum ferritin levels within the target range

References:

https://en.wikipedia.org/wiki/Deferasirox

http://www.exjade.com/about-exjade/safety.jsp

 

 

Share It

Order image

Order Your
Prescription

Pre-order your
prescription online now

We’ll text you when it’s ready

Order Now

Do you have a
Question?

Ask now

Like Us on Facebook